世界の心筋梗塞治療薬市場は2023年に155億6,000万米ドルに達すると推定され、2024年から2032年の予測期間にわたって4.19%のCAGRで成長すると予測されています。
心筋梗塞の治療には、心臓発作の影響を管理および緩和することを目的としたさまざまな治療法が含まれます。これには、冠動脈を塞ぐ血栓を溶かす血栓溶解療法などの急性介入や、血流を回復させるための血管形成術やステント留置などの経皮的冠動脈インターベンション（PCI）が含まれます。抗血小板薬、抗凝固薬、ベータ遮断薬などの薬剤は、心臓の作業負荷を軽減し、さらなる血栓形成を防ぐ重要な役割を果たします。長期的な管理には、生活習慣の変更、コレステロール値を管理するためのスタチン、血圧を制御するための薬剤が含まれる場合があります。これらの戦略は全体として、心臓機能を回復し、合併症を防ぎ、全体的な予後を改善することを目的としています。さらに、薬理学の進歩により、新しい抗凝固薬、抗血小板薬、心筋梗塞に関与する特定の経路を標的とする薬剤などの新薬が開発されています。これらの革新は、有効性を高め、副作用を減らすことを目的としています。
この大幅な成長は、過去15年間、世界中で死亡の主な原因となっている心血管疾患（CVD）の罹患率の増加に起因しています。座りがちな生活、不健康な食事、喫煙、人口の高齢化などの要因が心筋梗塞の発生率の上昇にさらに寄与しており、効果的な治療法の需要を促進しています。治療法の技術的進歩も、市場成長の重要な原動力です。遺伝子治療、幹細胞治療、個別化医療アプローチなどの新しい治療法の導入を含む、医薬品開発における継続的な革新により、治療結果が向上し、死亡率が低下することが期待されています。遠隔医療や遠隔患者モニタリングの採用により、特に医療サービスが行き届いていない地域で医療サービスへのアクセスが向上し、市場の範囲が拡大します。
世界の心筋梗塞治療薬市場の主要地域には、北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東およびアフリカが含まれます。2023年には、確立された医療インフラ、心血管疾患の高い有病率、および強力な研究開発活動に支えられ、北アメリカが収益の面で市場を支配します。この地域は、革新的な医薬品や高度な医療技術などの最先端の治療法の恩恵を受けており、医療へのアクセスと患者管理に重点が置かれており、市場での主導的な地位を推進しています。ヨーロッパは、高齢者人口の増加と医療費の増加に牽引され、これに続いています。アジア太平洋地域は、心血管の健康に対する意識の高まり、医療システムの改善、可処分所得の増加により、2024年から2032年の予測期間中に最も高い成長率で成長すると予想されています。
目次
Table of Contents
Chapter 1. Global Myocardial Infarction Therapeutics Market Executive Summary
1.1. Global Myocardial Infarction Therapeutics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Therapeutic Class
1.3.2. By Route of Administration
1.3.3. By Indication
1.3.4. By Mechanism of Action
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Myocardial Infarction Therapeutics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Myocardial Infarction Therapeutics Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Cardiovascular Diseases
3.1.2. Technological Advancements in MI Treatment
3.1.3. Increasing Healthcare Expenditure
3.2. Market Challenges
3.2.1. High Cost of Treatment
3.2.2. Limited Accessibility in Developing Regions
3.3. Market Opportunities
3.3.1. Development of Novel Treatments
3.3.2. Adoption of Telemedicine and Remote Patient Monitoring
3.3.3. Shift Towards Minimally Invasive Procedures
Chapter 4. Global Myocardial Infarction Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Myocardial Infarction Therapeutics Market Size & Forecasts by Therapeutic Class 2022-2032
5.1. Segment Dashboard
5.2. Global Myocardial Infarction Therapeutics Market: Therapeutic Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Antiplatelet Agents
5.2.2. Antithrombotic Agents
5.2.3. Nitrates
5.2.4. Calcium Channel Blockers
5.2.5. Lipid-Lowering Agents
Chapter 6. Global Myocardial Infarction Therapeutics Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Myocardial Infarction Therapeutics Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oral
6.2.2. Intravenous
6.2.3. Subcutaneous
6.2.4. Transdermal
Chapter 7. Global Myocardial Infarction Therapeutics Market Size & Forecasts by Indication 2022-2032
7.1. Segment Dashboard
7.2. Global Myocardial Infarction Therapeutics Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. ST-Elevation Myocardial Infarction (STEMI)
7.2.2. Non-ST-Elevation Myocardial Infarction (NSTEMI)
7.2.3. Unstable Angina
Chapter 8. Global Myocardial Infarction Therapeutics Market Size & Forecasts by Mechanism of Action 2022-2032
8.1. Segment Dashboard
8.2. Global Myocardial Infarction Therapeutics Market: Mechanism of Action Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Platelet Aggregation Inhibitors (P2Y12 Inhibitors, GPIIb/IIIa Inhibitors)
8.2.2. Thrombin Inhibitors
8.2.3. Anticoagulants
8.2.4. Calcium Channel Blockers
8.2.5. HMG-CoA Reductase Inhibitors
Chapter 9. Global Myocardial Infarction Therapeutics Market Size & Forecasts by Region 2022-2032
9.1. North America Myocardial Infarction Therapeutics Market
9.1.1. U.S. Myocardial Infarction Therapeutics Market
9.1.1.1. Therapeutic Class Breakdown Size & Forecasts, 2022-2032
9.1.1.2. Route of Administration Breakdown Size & Forecasts, 2022-2032
9.1.1.3. Indication Breakdown Size & Forecasts, 2022-2032
9.1.1.4. Mechanism of Action Breakdown Size & Forecasts, 2022-2032
9.1.2. Canada Myocardial Infarction Therapeutics Market
9.2. Europe Myocardial Infarction Therapeutics Market
9.2.1. U.K. Myocardial Infarction Therapeutics Market
9.2.2. Germany Myocardial Infarction Therapeutics Market
9.2.3. France Myocardial Infarction Therapeutics Market
9.2.4. Spain Myocardial Infarction Therapeutics Market
9.2.5. Italy Myocardial Infarction Therapeutics Market
9.2.6. Rest of Europe Myocardial Infarction Therapeutics Market
9.3. Asia-Pacific Myocardial Infarction Therapeutics Market
9.3.1. China Myocardial Infarction Therapeutics Market
9.3.2. India Myocardial Infarction Therapeutics Market
9.3.3. Japan Myocardial Infarction Therapeutics Market
9.3.4. Australia Myocardial Infarction Therapeutics Market
9.3.5. South Korea Myocardial Infarction Therapeutics Market
9.3.6. Rest of Asia Pacific Myocardial Infarction Therapeutics Market
9.4. Latin America Myocardial Infarction Therapeutics Market
9.4.1. Brazil Myocardial Infarction Therapeutics Market
9.4.2. Mexico Myocardial Infarction Therapeutics Market
9.4.3. Rest of Latin America Myocardial Infarction Therapeutics Market
9.5. Middle East & Africa Myocardial Infarction Therapeutics Market
9.5.1. Saudi Arabia Myocardial Infarction Therapeutics Market
9.5.2. South Africa Myocardial Infarction Therapeutics Market
9.5.3. Rest of Middle East & Africa Myocardial Infarction Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bristol-Myers Squibb Company
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Boehringer Ingelheim International GmbH
10.3.3. Merck & Co., Inc.
10.3.4. Teva Pharmaceutical Industries Ltd.
10.3.5. Abbott Laboratories
10.3.6. Novartis AG
10.3.7. Sanofi Aventis US, LLC
10.3.8. AstraZeneca plc
10.3.9. Pfizer Inc.
10.3.10. Roche Holding AG
10.3.11. Bayer AG
10.3.12. Eli Lilly and Company
10.3.13. Johnson & Johnson
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Myocardial Infarction Therapeutics market, report scope
TABLE 2. Global Myocardial Infarction Therapeutics market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Myocardial Infarction Therapeutics market estimates & forecasts by Therapeutic Class 2022-2032 (USD Billion)
TABLE 4. Global Myocardial Infarction Therapeutics market estimates & forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 5. Global Myocardial Infarction Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Myocardial Infarction Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Myocardial Infarction Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Myocardial Infarction Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Myocardial Infarction Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Myocardial Infarction Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Myocardial Infarction Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Myocardial Infarction Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Myocardial Infarction Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Myocardial Infarction Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Myocardial Infarction Therapeutics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Myocardial Infarction Therapeutics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Myocardial Infarction Therapeutics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Myocardial Infarction Therapeutics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Myocardial Infarction Therapeutics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Myocardial Infarction Therapeutics market estimates & forecasts by segment 2022-2032 (USD Billion)
.....
This list is not complete, the final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Myocardial Infarction Therapeutics market, research methodology
FIG 2. Global Myocardial Infarction Therapeutics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Myocardial Infarction Therapeutics market, key trends 2023
FIG 5. Global Myocardial Infarction Therapeutics market, growth prospects 2022-2032
FIG 6. Global Myocardial Infarction Therapeutics market, porters 5 force model
FIG 7. Global Myocardial Infarction Therapeutics market, PESTEL analysis
FIG 8. Global Myocardial Infarction Therapeutics market, value chain analysis
FIG 9. Global Myocardial Infarction Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Myocardial Infarction Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Myocardial Infarction Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Myocardial Infarction Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Myocardial Infarction Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Myocardial Infarction Therapeutics market, regional snapshot 2022 & 2032
FIG 15. North America Myocardial Infarction Therapeutics market 2022 & 2032 (USD Billion)
FIG 16. Europe Myocardial Infarction Therapeutics market 2022 & 2032 (USD Billion)
FIG 17. Asia-Pacific Myocardial Infarction Therapeutics market 2022 & 2032 (USD Billion)
FIG 18. Latin America Myocardial Infarction Therapeutics market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Myocardial Infarction Therapeutics market 2022 & 2032 (USD Billion)
FIG 20. Global Myocardial Infarction Therapeutics market, company market share analysis (2023)
.....
This list is not complete, the final report does contain more than 50 figures. The list may be updated in the final deliverable.
